Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Cantor Fitzgerald
Johnson and Johnson
Mallinckrodt
Covington
Moodys
Teva
Cipla
Boehringer Ingelheim

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202334

« Back to Dashboard

NDA 202334 describes LEVONORGESTREL, which is a drug marketed by Wyeth Pharms Inc, Glenmark Pharms Ltd, Lotus Pharm Co Ltd, Lupin Ltd, Mylan Labs Ltd, Novel Labs Inc, Oc Pharma, Perrigo R And D, Reckitt Benckiser, Watson Labs, Watson Labs Inc, Amneal Pharms, Glenmark Generics, Mayne Pharma, and Barr, and is included in thirty-seven NDAs. It is available from fifteen suppliers. Additional details are available on the LEVONORGESTREL profile page.

The generic ingredient in LEVONORGESTREL is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 202334
Tradename:LEVONORGESTREL
Applicant:Perrigo R And D
Ingredient:levonorgestrel
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 202334
Suppliers and Packaging for NDA: 202334
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVONORGESTREL levonorgestrel TABLET;ORAL 202334 ANDA L. Perrigo Company 0113-2003 0113-2003-12 1 BLISTER PACK in 1 CARTON (0113-2003-12) > 1 TABLET in 1 BLISTER PACK
LEVONORGESTREL levonorgestrel TABLET;ORAL 202334 ANDA Rapha Pharmaceuticals, Inc. 69953-514 69953-514-01 1 BLISTER PACK in 1 CARTON (69953-514-01) > 1 mg in 1 BLISTER PACK

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength1.5MG
Approval Date:Aug 20, 2014TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Colorcon
Fuji
Daiichi Sankyo
Deloitte
Federal Trade Commission
QuintilesIMS
Julphar
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot